Literature DB >> 25337239

A four actin-binding protein signature model for poor prognosis of patients with esophageal squamous cell carcinoma.

Zhang-Mei Peng1, Wei Yu1, Ying Xie1, Wei-Hua Peng1, Hui-Hui Cao1, Jin-Hui Shen2, Zhi-Yong Wu3, En-Min Li4, Li-Yan Xu1.   

Abstract

The actin cytoskeleton is a dynamic structure with actin-binding proteins (ABPs) playing an essential role in the regulation of migration, differentiation and signal transduction in all eukaryotic cells. We examined the relationship between altered expression of four ABPs and clinical parameters in esophageal squamous cell carcinoma (ESCC). To this end, we analyzed 152 formalin-fixed and paraffin-embedded esophageal curative resection specimens by immunohistochemistry for tensin, profilin-1, villin-1 and talin. A molecular predictor model, based on the combined expression of the four proteins, was developed to correlate the expression pattern of the four ABPs with clinical factors and prognosis of ESCC. According to the results, weak significance was found for tensin in lymph node metastasis (P=0.033), and profilin-1 in pTNM stage (P=0.031). However, our four-protein model showed strong correlation with the 5-year overall survival rate (P=0.002). Similarly, Kendall's tau-b test also showed the relationship between the collective expression pattern of the four ABPs with lymph node metastasis (P=0.005) and pTNM stage (P=0.001). Our results demonstrate that the collective protein expression pattern of four actin-binding proteins could be a biomarker to estimate the prognosis of ESCC patients.

Entities:  

Keywords:  Actin-binding protein; a molecular prognostic model; esophageal squamous cell carcinoma; prognosis

Mesh:

Substances:

Year:  2014        PMID: 25337239      PMCID: PMC4203210     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  40 in total

1.  ONCOMINE: a cancer microarray database and integrated data-mining platform.

Authors:  Daniel R Rhodes; Jianjun Yu; K Shanker; Nandan Deshpande; Radhika Varambally; Debashis Ghosh; Terrence Barrette; Akhilesh Pandey; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

Review 2.  Talin: an emerging focal point of adhesion dynamics.

Authors:  Anjana Nayal; Donna J Webb; Alan F Horwitz
Journal:  Curr Opin Cell Biol       Date:  2004-02       Impact factor: 8.382

Review 3.  Cytoskeletal proteins talin and vinculin in integrin-mediated adhesion.

Authors:  D R Critchley
Journal:  Biochem Soc Trans       Date:  2004-11       Impact factor: 5.407

4.  Talin-1 correlates with reduced invasion and migration in human hepatocellular carcinoma cells.

Authors:  Kun-Peng Fang; Jian-Lin Zhang; Yan-Hong Ren; Ye-Ben Qian
Journal:  Asian Pac J Cancer Prev       Date:  2014

5.  Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach.

Authors:  Mads Grønborg; Troels Zakarias Kristiansen; Akiko Iwahori; Rubens Chang; Raghunath Reddy; Norihiro Sato; Henrik Molina; Ole Nørregaard Jensen; Ralph H Hruban; Michael G Goggins; Anirban Maitra; Akhilesh Pandey
Journal:  Mol Cell Proteomics       Date:  2005-10-08       Impact factor: 5.911

6.  Tyrosine phosphorylation of villin regulates the organization of the actin cytoskeleton.

Authors:  L Zhai; P Zhao; A Panebra; A L Guerrerio; S Khurana
Journal:  J Biol Chem       Date:  2001-08-10       Impact factor: 5.157

Review 7.  Myosin II and mechanotransduction: a balancing act.

Authors:  Kristopher Clark; Michiel Langeslag; Carl G Figdor; Frank N van Leeuwen
Journal:  Trends Cell Biol       Date:  2007-02-21       Impact factor: 20.808

8.  Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma.

Authors:  H Zhang; L Xu; D Xiao; J Xie; H Zeng; W Cai; Y Niu; Z Yang; Z Shen; E Li
Journal:  J Clin Pathol       Date:  2006-03-08       Impact factor: 3.411

9.  Suppression of tumorigenicity in breast cancer cells by the microfilament protein profilin 1.

Authors:  J Janke; K Schlüter; B Jandrig; M Theile; K Kölble; W Arnold; E Grinstein; A Schwartz; L Estevéz-Schwarz; P M Schlag; B M Jockusch; S Scherneck
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

10.  Profilin-1 is a negative regulator of mammary carcinoma aggressiveness.

Authors:  L Zou; M Jaramillo; D Whaley; A Wells; V Panchapakesa; T Das; P Roy
Journal:  Br J Cancer       Date:  2007-10-16       Impact factor: 7.640

View more
  9 in total

1.  A loss of profilin-1 in late-stage oral squamous cell carcinoma.

Authors:  Guy R Adami; Thomas N O'Callaghan; Antonia Kolokythas; Robert J Cabay; Yalu Zhou; Joel L Schwartz
Journal:  J Oral Pathol Med       Date:  2016-12-18       Impact factor: 4.253

Review 2.  Actin-Binding Proteins as Potential Biomarkers for Chronic Inflammation-Induced Cancer Diagnosis and Therapy.

Authors:  Yu-Gui Zhang; Jiang-Tao Niu; Hong-Wei Wu; Xin-Lei Si; Shu-Juan Zhang; Dong-Hui Li; Tian-Tian Bian; Yue-Feng Li; Xing-Ke Yan
Journal:  Anal Cell Pathol (Amst)       Date:  2021-06-05       Impact factor: 2.916

3.  A chromosomal passenger complex protein signature model predicts poor prognosis for non-small-cell lung cancer.

Authors:  Rong Xia; Sunxiao Chen; Yan Chen; Weiwei Zhang; Rongrong Zhu; Anmei Deng
Journal:  Onco Targets Ther       Date:  2015-04-07       Impact factor: 4.147

4.  Guttiferone K suppresses cell motility and metastasis of hepatocellular carcinoma by restoring aberrantly reduced profilin 1.

Authors:  Kaikai Shen; Zhichao Xi; Jianling Xie; Hua Wang; Chanlu Xie; C Soon Lee; Paul Fahey; Qihan Dong; Hongxi Xu
Journal:  Oncotarget       Date:  2016-08-30

5.  A novel molecular and clinical staging model to predict survival for patients with esophageal squamous cell carcinoma.

Authors:  Wei Wang; Zhiwei Wang; Jun Zhao; Min Wei; Xinghua Zhu; Qi He; Tianlong Ling; Xiaoyan Chen; Ziang Cao; Yixin Zhang; Lei Liu; Minxin Shi
Journal:  Oncotarget       Date:  2016-09-27

Review 6.  Forecast of actin-binding proteins as the oncotarget in osteosarcoma - a review of mechanism, diagnosis and therapy.

Authors:  Yucheng Fu; Wei Yu; Hongliu Cai; Anwei Lu
Journal:  Onco Targets Ther       Date:  2018-03-20       Impact factor: 4.147

7.  The expression of ubiquitin-conjugating enzyme E2C and KAI1 in ovarian carcinoma and their clinical significance.

Authors:  Yingying Gong; Danna Wang; Lu Lin; Junjun Dai; Lan Yu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

8.  Identification of a multidimensional transcriptome prognostic signature for lung adenocarcinoma.

Authors:  Jing Ye; Hui Liu; Zhi-Li Xu; Ling Zheng; Rong-Yu Liu
Journal:  J Clin Lab Anal       Date:  2019-08-11       Impact factor: 2.352

9.  Integrated analysis of genomic and transcriptomic profiles identified a prognostic immunohistochemistry panel for esophageal squamous cell cancer.

Authors:  Yue Yu; Zhihua Li; Chenjun Huang; Haisheng Fang; Fei Zhao; Yue Zhou; Xianglong Pan; Qifan Li; Yu Zhuang; Liang Chen; Jing Xu; Wei Wang
Journal:  Cancer Med       Date:  2019-12-02       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.